SERETIDE INHALER 25/125

SERETIDE INHALER 25/125 contains a combination of two active ingredients: salmeterol and fluticasone. It is primarily used for the long-term management of asthma and chronic obstructive pulmonary disease (COPD) in patients who require both a long-acting beta agonist (LABA) and an inhaled corticosteroid (ICS) for adequate control of their symptoms. Here is some information about SERETIDE INHALER 25/125:

Uses:

• Asthma: SERETIDE INHALER 25/125 is indicated for the regular treatment of asthma in patients aged 12 years and older. It helps to control symptoms and prevent asthma attacks by reducing inflammation and relaxing the muscles in the airways.
• Chronic Obstructive Pulmonary Disease (COPD): SERETIDE INHALER 25/125 is also used for the maintenance treatment of COPD, including chronic bronchitis and emphysema, in adults.

Composition:

• Salmeterol: Salmeterol is a long-acting beta agonist (LABA) that works by relaxing the muscles in the airways, thereby opening up the air passages and making it easier to breathe. It helps to prevent asthma attacks and COPD exacerbations.
• Fluticasone: Fluticasone is an inhaled corticosteroid (ICS) that reduces inflammation in the airways, thereby decreasing the frequency and severity of asthma symptoms and COPD exacerbations.

Dosage and Administration:

• SERETIDE INHALER 25/125 is usually administered via oral inhalation.
• The recommended dose is usually two inhalations twice daily, approximately 12 hours apart.
• It is essential to use SERETIDE INHALER 25/125 regularly for it to be effective in controlling asthma or COPD symptoms.
• Patients should be instructed on how to use the inhaler correctly to ensure optimal drug delivery to the lungs.

Side Effects:

Common side effects of SERETIDE INHALER 25/125 may include:

• Sore throat
• Hoarseness
• Thrush (oral fungal infection)
• Headache
• Nausea
• Cough
• Muscle cramps

Serious side effects may include allergic reactions, paradoxical bronchospasm (worsening of breathing difficulties), and adrenal suppression (especially with high doses or prolonged use).

Precautions:

• SERETIDE INHALER 25/125 should not be used as a rescue medication for acute asthma attacks or COPD exacerbations. Patients should have a separate reliever inhaler (e.g., salbutamol) for immediate relief of symptoms.
• It is essential to rinse the mouth with water after each use of the inhaler to minimize the risk of developing oral thrush.
• Patients should be monitored regularly for signs of worsening asthma or COPD symptoms and for potential side effects of the medication.

When Not to Use: SERETIDE INHALER 25/125 is contraindicated in patients with a known hypersensitivity to salmeterol, fluticasone, or any other components of the inhaler.

FAQ:

1. How long does it take for SERETIDE INHALER 25/125 to start working?
   • Patients may start to notice an improvement in their symptoms within a few days of starting treatment with SERETIDE INHALER 25/125, but it may take up to several weeks for the full benefits to be achieved.
2. Can SERETIDE INHALER 25/125 be used during pregnancy or breastfeeding?
   • The use of SERETIDE INHALER 25/125 during pregnancy or breastfeeding should be carefully considered and discussed with a healthcare professional, weighing the potential benefits against the risks to the mother and baby.
3. What should I do if I miss a dose of SERETIDE INHALER 25/125?
   • If a dose is missed, patients should take it as soon as they remember, unless it is almost time for the next dose. In that case, the missed dose should be skipped, and the regular dosing schedule resumed. Doubling up on doses should be avoided.
4. Can SERETIDE INHALER 25/125 cause weight gain?
   • Weight gain is not a common side effect of SERETIDE INHALER 25/125. However, systemic corticosteroids like fluticasone may cause weight gain with long-term use, although the effect is usually modest.
5. Is SERETIDE INHALER 25/125 a steroid inhaler?
   • Yes, SERETIDE INHALER 25/125 contains fluticasone, which is a corticosteroid used to reduce inflammation in the